Chen W, Zhang T, Bai Y, Deng H, Yang F, Zhu R, et al
Compounded options (not FDA-approved): Compounded Semaglutide - injectable, once weekly Compounded Tirzepatide - injectable, once weekly Compounded Oral Semaglutide - once-daily dissolving tablet Compounded Oral Tirzepatide - once-daily dissolving tablet Brand-name options (FDA-approved for their indicated uses): Ozempic - brand-name semaglutide
Synergistic use can harness their strengths, though rigorous human trials are still needed
other market factors may also have contributed
But as a therapeutic peptide , MOTS-c is supplemental: it fills the vacancy that develops over time and ensures healthy ongoing interrelations in the bodys biochemistry
So that's where I'm at now